Josiane Machado Vieira Mattoso
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Josiane Machado Vieira Mattoso has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Marcelo Luiz Lima Brandão
Institute of Technology in Immunobiologicals, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil
3 shared publications - Greice Maria Silva da Conceição
Systems, Analytical Indicators and Data Section, Department of Quality Control, Bio- Manguinhos, Fiocruz, Rio de Janeiro, Brazil
2 shared publications - Igor Barbosa da Silva
Laboratory of Microbiology Control, Department of Quality Control, Bio-Manguinhos/Fiocruz, Rio de Janeiro/RJ, Brazil
2 shared publications - Jeancarlo Pereira dos Anjos
Centro de Ciências Naturais e Humanas, CCNH, Universidade Federal do ABC, Santo André 09606-070, SP, Brazil, Brazil
2 shared publications - Leticia de Alencar Pereira Rodrigues
SENAI Institute for Innovation in Advanced Health Systems, SENAI CIMATEC University, Salvador 41650-010, BA, Brazil
2 shared publications - Ana Carolina Ferreira Ballestê Ajorio
Laboratory of Microbiology Control, Department of Quality Control, Bio-Manguinhos/Fiocruz, Brazil
1 shared publication
Latest Publications
- Open Access
Comparison of Statistical Process Control Models for Monitoring the Biological Burden of a Buffer Solution Used as Input to Produce an Attenuated Viral Vaccine
The pharmaceutical industry faces various production challenges. Bioburden control is essential, and appropriate strategies and procedures must be implemented at all stages of production to prevent microbial contamination and comply with regulatory standards. Quality tools can provide important information for data management in production processes. The objective of this study was to compare two types of statistical process control charts (Laney’s U-chart and Bell distribution) in monitoring the bioburden of a buffer solution used as an input to produce an attenuated viral vaccine. Bioburden data for the buffer solution were obtained over a two-year period. The results showed that the analyzed products met the regulatory specifications, as 99% of them presented ≤ 10 colony-forming units (CFU)/100 mL after filtration. Various microorganisms were identified in the buffer solution, including species from the genus Bacillus spp., Micrococcus spp., Kocuria spp., Staphylococcus spp., and Acinetobacter spp. The Bell distribution proved to be statistically more suitable for application in the management of bioburden data for the buffer solution since the limits were closer to the specified value and could more effectively assist in the investigation of process deviations in the production of an attenuated viral vaccine.
Open AccessComparison of Statistical Process Control Models for Monitoring the Biological Burden of a Buffer Solution Used as Input to Produce an Attenuated Viral Vaccine
The pharmaceutical industry faces various production challenges. Bioburden control is essential, and appropriate strategies and procedures must be implemented at all stages of production to prevent microbial contamination and comply with regulatory standards. Quality tools can provide important information for data management in production processes. The objective of this study was to compare two types of statistical process control charts (Laney’s U-chart and Bell distribution) in monitoring the bioburden of a buffer solution used as an input to produce an attenuated viral vaccine. Bioburden data for the buffer solution were obtained over a two-year period. The results showed that the analyzed products met the regulatory specifications, as 99% of them presented ≤ 10 colony-forming units (CFU)/100 mL after filtration. Various microorganisms were identified in the buffer solution, including species from the genus Bacillus spp., Micrococcus spp., Kocuria spp., Staphylococcus spp., and Acinetobacter spp. The Bell distribution proved to be statistically more suitable for application in the management of bioburden data for the buffer solution since the limits were closer to the specified value and could more effectively assist in the investigation of process deviations in the production of an attenuated viral vaccine.
- 28 June 2024
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 79 (2) , 125-156
Quantitative and Qualitative Evaluation of Microorganism Profile Identified in Bioburden Analysis in a Biopharmaceutical Facility in Brazil: Criteria for Classification and Management of Results
Microbiological contamination may cause microbial proliferation and consequently additional problems for pharmaceutical companies through production stoppage, product contamination, investigations of process deviations, out-of-specification results and product disposal. This is one of the major concerns of the regulatory health agencies. Microbiological load (bioburden) may represent a potential risk for patients if the sterilization process is not effective and/or due to the production of toxins. Although bioburden can be eliminated by terminal sterilization or filtration processes, it is important to monitor the amount and determine the identity and characteristics of the microorganisms present prior to final processing. The application of microorganism identification systems is crucial for identifying the type of contamination, which can be extremely useful for investigating. The aim of this study was to evaluate the profiles of microorganisms identified in bioburden assays from solutions, culture medias, and products (SCP) from a pharmaceutical industry facility. From 2018-2020, a total of 1,078 samples from 857 different lots of SCP were analyzed and isolated microorganisms were identified. A prefiltering step was included after March 2020, in order to reduce the bioburden before sterilizing filtration. Criteria for the definition and management of microorganisms identified were evaluated after an integrative bibliographic review, and three groups were proposed (critical, objectionable, and nonobjectionable microorganisms). For the samples that did not include prefiltering (n=636), 227 (35.7%) presented microbial growth. For those that included prefiltering, before prefiltering (n=221), 60.6% presented microbial growth, and after prefiltering, this value was reduced to 4.1%, which can be attributed to a contamination during the sampling or a wrong filtering. From the samples that presented microbial growth, 678 microorganisms were identified as bacteria and 59 as molds and yeasts. A total of 120 microorganisms (56 and 27 Gram-positive and negative bacteria, respectively, 31 yeasts, and six filamentous molds) could not be identified, and the remaining microorganisms were classified as objectionable (n=507; 82.2%), nonobjectionable (n=103; 16.7%) and critical (n=7; 1.1%). Most of the bioburden species (>80.0%) were considered objectionable microorganisms. A process for classification and management of bioburden analysis results based on a literature review of pathogenic and physiological characteristics of the microorganisms was proposed.
- 28 June 2024
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 79 (2) , 125-156
Quantitative and Qualitative Evaluation of Microorganism Profile Identified in Bioburden Analysis in a Biopharmaceutical Facility in Brazil: Criteria for Classification and Management of Results
Microbiological contamination may cause microbial proliferation and consequently additional problems for pharmaceutical companies through production stoppage, product contamination, investigations of process deviations, out-of-specification results and product disposal. This is one of the major concerns of the regulatory health agencies. Microbiological load (bioburden) may represent a potential risk for patients if the sterilization process is not effective and/or due to the production of toxins. Although bioburden can be eliminated by terminal sterilization or filtration processes, it is important to monitor the amount and determine the identity and characteristics of the microorganisms present prior to final processing. The application of microorganism identification systems is crucial for identifying the type of contamination, which can be extremely useful for investigating. The aim of this study was to evaluate the profiles of microorganisms identified in bioburden assays from solutions, culture medias, and products (SCP) from a pharmaceutical industry facility. From 2018-2020, a total of 1,078 samples from 857 different lots of SCP were analyzed and isolated microorganisms were identified. A prefiltering step was included after March 2020, in order to reduce the bioburden before sterilizing filtration. Criteria for the definition and management of microorganisms identified were evaluated after an integrative bibliographic review, and three groups were proposed (critical, objectionable, and nonobjectionable microorganisms). For the samples that did not include prefiltering (n=636), 227 (35.7%) presented microbial growth. For those that included prefiltering, before prefiltering (n=221), 60.6% presented microbial growth, and after prefiltering, this value was reduced to 4.1%, which can be attributed to a contamination during the sampling or a wrong filtering. From the samples that presented microbial growth, 678 microorganisms were identified as bacteria and 59 as molds and yeasts. A total of 120 microorganisms (56 and 27 Gram-positive and negative bacteria, respectively, 31 yeasts, and six filamentous molds) could not be identified, and the remaining microorganisms were classified as objectionable (n=507; 82.2%), nonobjectionable (n=103; 16.7%) and critical (n=7; 1.1%). Most of the bioburden species (>80.0%) were considered objectionable microorganisms. A process for classification and management of bioburden analysis results based on a literature review of pathogenic and physiological characteristics of the microorganisms was proposed.